Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 12387
TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699832(US20240335431, Example 13)
Affinity DataIC50: 4nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699829(US20240335431, Example 10)
Affinity DataIC50: 4nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699830(US20240335431, Example 11)
Affinity DataIC50: 4nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699831(US20240335431, Example 12)
Affinity DataIC50: 6nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699858(US20240335431, Example 39)
Affinity DataIC50: 7nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699842(US20240335431, Example 23)
Affinity DataIC50: 7nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699861(US20240335431, Example 42)
Affinity DataIC50: 9nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699856(US20240335431, Example 37)
Affinity DataIC50: 9nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699885(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0]-hexane-2-c...)
Affinity DataIC50: 9nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699860(US20240335431, Example 41)
Affinity DataIC50: 10nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699850(US20240335431, Example 31)
Affinity DataIC50: 10nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699857(US20240335431, Example 38)
Affinity DataIC50: 13nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699868(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0-]hexane-2-c...)
Affinity DataIC50: 13nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699881(US20240335431, Example 53-3)
Affinity DataIC50: 14nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699883(US20240335431, Example 54)
Affinity DataIC50: 15nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699866(US20240335431, Example 47)
Affinity DataIC50: 15nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699875(US20240335431, Example 52-1)
Affinity DataIC50: 16nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699840(US20240335431, Example 21)
Affinity DataIC50: 16nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699838(US20240335431, Example 19 | BDBM699847)
Affinity DataIC50: 16nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699838(US20240335431, Example 19 | BDBM699847)
Affinity DataIC50: 17nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699849(US20240335431, Example 30)
Affinity DataIC50: 17nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699834(US20240335431, Example 15)
Affinity DataIC50: 17nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699859(US20240335431, Example 40)
Affinity DataIC50: 18nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699876(US20240335431, Example 52-2)
Affinity DataIC50: 18nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699824(US20240335431, Example 5)
Affinity DataIC50: 18nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699843(US20240335431, Example 24)
Affinity DataIC50: 19nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699839(US20240335431, Example 20 | BDBM699848)
Affinity DataIC50: 20nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699862(US20240335431, Example 43)
Affinity DataIC50: 20nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699835(US20240335431, Example 16)
Affinity DataIC50: 21nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699836(US20240335431, Example 17)
Affinity DataIC50: 21nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699874(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0]hexane-2-ca...)
Affinity DataIC50: 22nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699839(US20240335431, Example 20 | BDBM699848)
Affinity DataIC50: 22nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699826(US20240335431, Example 7)
Affinity DataIC50: 24nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699855(US20240335431, Example 36)
Affinity DataIC50: 24nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699846(US20240335431, Example 27)
Affinity DataIC50: 25nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699841(US20240335431, Example 22)
Affinity DataIC50: 25nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699822(US20240335431, Example 3)
Affinity DataIC50: 25nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699827(US20240335431, Example 8)
Affinity DataIC50: 27nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699844(US20240335431, Example 25)
Affinity DataIC50: 27nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699872((S)-2-(3-(1-(5,5-Dimethylpyrrolidine-2-carbonyl)pi...)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699853(US20240335431, Example 34)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699870((S)-2-(3-(1-(4-Azaspiro[2.4]heptane-5-carbonyl)pip...)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699793(US20240335431, Example 1)
Affinity DataIC50: 29nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699891((1-((S)-4-Azaspiro[2.4]heptane-5-carbonyl)piperidi...)
Affinity DataIC50: 30nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699888(2-(3-(1-((1S,2S,5R)-3-Azabicyclo[3.1.0-]hexane-2-c...)
Affinity DataIC50: 33nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699865(US20240335431, Example 46)
Affinity DataIC50: 34nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699864(US20240335431, Example 45)
Affinity DataIC50: 36nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699851(US20240335431, Example 32)
Affinity DataIC50: 36nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699837(US20240335431, Example 18)
Affinity DataIC50: 37nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

TargetMenin(Human)
Acerta Pharma

US Patent
LigandPNGBDBM699852(US20240335431, Example 33)
Affinity DataIC50: 37nMAssay Description:Compounds were tested in a biochemical binding assay using Menin protein at 2 nM (N6his-tev-Menin_4i80, PB-20-1459) and the substrate cRho110-Ahx-MBM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
US Patent

Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: